Investigation and pending class action lawsuit on behalf of direct purchasers for the opioid analgensic, Oxycontin.
The class action complaint alleges that Purdue Pharmaceuticals, L.P. obtained patents protecting Oxycontin by defrauding the U.S. Patent and Trademark Office, leading it to believe the drug was novel, when in fact many prior opioid painkillers presaged Oxycontin.
Do not change medications without first consulting your doctor.
Defendant Details
Name (Stock Symbol)
Brief Description
Purdue Pharmaceuticals
Purdue Pharmaceuticals is a pharmaceutical company.